NDC 0713-0805 – Tazarotene
Tazarotene .5 mg/g · Gel · Topical
Product NDC0713-0805
Product details
- Brand name
- Tazarotene
- Generic name
- Tazarotene
- Labeler
- Cosette Pharmaceuticals, Inc.
- Dosage form
- Gel
- Route
- Topical
- Marketing category
- ANDA · ANDA215433
- Marketed since
- September 14, 2022
- Listing expires
- December 31, 2026
- Pharmacologic class
- Retinoid
Active ingredients
- Tazarotene .5 mg/g
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0713-0805-31 | 1 TUBE in 1 CARTON (0713-0805-31) / 30 g in 1 TUBE | Sep 14, 2022 |
| 0713-0805-99 | 1 TUBE in 1 CARTON (0713-0805-99) / 100 g in 1 TUBE | Sep 14, 2022 |
Other Tazarotene products
- 72162-2202 Tazarotene 1 mg/g · Gel · Bryant Ranch Prepack
- 0713-0804 Tazarotene 1 mg/g · Gel · Cosette Pharmaceuticals, Inc.
- 45802-436 Tazarotene .5 mg/g · Gel · Padagis Israel Pharmaceuticals Ltd
- 45802-442 Tazarotene 1 mg/g · Gel · Padagis Israel Pharmaceuticals Ltd
- 73473-309 Tazarotene .5 mg/g · Gel · Solaris Pharma Corporation
- 73473-310 Tazarotene 1 mg/g · Gel · Solaris Pharma Corporation
- 72162-2420 Tazarotene .5 mg/g · Cream · Bryant Ranch Prepack
- 0713-0670 Tazarotene 1 mg/g · Cream · Cosette Pharmaceuticals, Inc.
- 0713-0765 Tazarotene .5 mg/g · Cream · Cosette Pharmaceuticals, Inc.
- 68308-745 Tazarotene 1 mg/g · Cream · Mayne Pharma
- 68308-685 Tazarotene 1 mg/g · Aerosol, Foam · Mayne Pharma Inc.
- 45802-706 Tazarotene .5 mg/g · Cream · Padagis Israel Pharmaceuticals Ltd